Why is Titan Biotech falling/rising?

As of 28-Aug, Titan Biotech Ltd is experiencing a significant rise in its stock price, currently at 638.25, reflecting an increase of 91.4 or 16.71%. The stock has shown strong performance today, outperforming its sector by 18.4% and achieving a consecutive gain over the last three days with a total return of 43.12%. Additionally, it reached an intraday high of Rs 647.05 and has been trading above its moving averages across various time frames. The stock's recent performance is bolstered by a low debt-to-equity ratio and consistent returns over the past three years, although it faces challenges with poor long-term growth and a high valuation compared to peers.
In the broader market context, Titan Biotech's short-term returns have significantly outperformed the Sensex, which has declined by 2.34% over the past week while Titan Biotech has surged by 40.55%. This stark contrast highlights the stock's strong momentum amidst a generally weak market. Despite the positive short-term performance, concerns regarding its long-term growth potential and profitability, as indicated by a decline in operating profit and a high price-to-book ratio, may temper investor enthusiasm moving forward.